The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
about
New approaches in primary central nervous system lymphoma.ABC transporters at the blood-brain barrier.A Review on Microdialysis Calibration Methods: the Theory and Current Related Efforts.Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier.
P2860
The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
@en
The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
@nl
type
label
The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
@en
The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
@nl
prefLabel
The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
@en
The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
@nl
P2093
P2860
P356
P1476
The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
@en
P2093
James M Gallo
Ramola Sane
Rong Zhang
Shu-Pei Wu
P2860
P304
P356
10.1124/DMD.113.055228
P577
2014-01-24T00:00:00Z